

Lead Product(s) : Transcrocetin Sodium
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : LEAF4Life
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Transcrocetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Sarcoma.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 26, 2024
Lead Product(s) : Transcrocetin Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : LEAF4Life
Deal Size : Inapplicable
Deal Type : Inapplicable
